Compounds > phosphorus
Page last updated: 2024-09-04

phosphorus and cardiovascular agents

phosphorus has been researched along with cardiovascular agents in 5 studies

Compound Research Comparison

Studies
(phosphorus)		Trials
(phosphorus)		Recent Studies (post-2010)
(phosphorus)		Studies
(cardiovascular agents)		Trials
(cardiovascular agents)		Recent Studies (post-2010) (cardiovascular agents)
48,0741,12617,13917,6451,4806,891

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goos, H; Gründer, W; Keller, T; Krause, EG; Mest, HJ; Pissarek, M1
Gründer, W; Keller, T; Krause, EG; Lindenau, KF; Pissarek, M1
Arsenian, MA; Cafasso, CM; New, PS1
LETIZIA, G; MERCADANTE, T1
Anker, SD; Doehner, W; Hudzik, B; Jankowska, EA; Kawecka, E; Kokocińska, D; Myrda, K; Niedziela, J; Nowak, J; Partyka, R; Poloński, L; Ponikowski, P; Rozentryt, P; Rywik, T; Szyguła, B; von Haehling, S1

Other Studies

5 other study(ies) available for phosphorus and cardiovascular agents

ArticleYear
Action of iloprost and PGE1 on global ischemic and reperfused myocardium: a 31P-NMR-study.
    Biomedica biochimica acta, 1988, Volume: 47, Issue:10-11

    Topics: Alprostadil; Animals; Cardiovascular Agents; Coronary Disease; Drug Interactions; Energy Metabolism; Epoprostenol; Heart; Iloprost; Magnetic Resonance Spectroscopy; Male; Myocardium; Perfusion; Phosphorus; Rats; Rats, Inbred Strains

1988
PGE1 and iloprost affect the high energy phosphates in the global ischemic and reperfused rat heart: a 31P-NMR study.
    Biomedica biochimica acta, 1989, Volume: 48, Issue:1

    Topics: Adenosine Triphosphate; Alprostadil; Animals; Cardiovascular Agents; Coronary Disease; Epoprostenol; Heart; Iloprost; Kinetics; Magnetic Resonance Spectroscopy; Male; Myocardial Reperfusion; Myocardium; Phosphates; Phosphocreatine; Phosphorus; Rats; Rats, Inbred Strains; Reference Values

1989
Safety, tolerability, and efficacy of a glucose-insulin-potassium-magnesium-carnitine solution in acute myocardial infarction.
    The American journal of cardiology, 1996, Aug-15, Volume: 78, Issue:4

    Topics: Aged; Blood Glucose; Calcium; Cardiovascular Agents; Carnitine; Diuretics; Drug Tolerance; Female; Furosemide; Glucose; Humans; Hypertonic Solutions; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Magnesium; Male; Myocardial Infarction; Phosphorus; Potassium; Safety; Thrombolytic Therapy

1996
[Guaiacol-glycerin ether and muscular phosphoric synthesis; experimental research].
    Acta anaesthesiologica, 1956, Volume: 7, Issue:6

    Topics: Cardiovascular Agents; Ether; Ethers; Glycerol; Guaiacol; Muscle Relaxants, Central; Muscles; Musculoskeletal Physiological Phenomena; Phosphorus

1956
Serum phosphorus level is related to degree of clinical response to up-titration of heart failure pharmacotherapy.
    International journal of cardiology, 2014, Nov-15, Volume: 177, Issue:1

    Topics: Cardiovascular Agents; Europe; Female; Follow-Up Studies; Heart Failure; Homeostasis; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphorus; Prevalence; Prognosis; Retrospective Studies; Severity of Illness Index

2014